Chang, J.; Choi, S.; Kim, K.; Park, S.M.
Cardiovascular Safety and Possible Benefit of a 5-Alpha Reductase Inhibitor among Benign Prostatic Hyperplasia Patients, A Nationally Representative Cohort of Korean Men. J. Clin. Med. 2019, 8, 733.
https://doi.org/10.3390/jcm8050733
AMA Style
Chang J, Choi S, Kim K, Park SM.
Cardiovascular Safety and Possible Benefit of a 5-Alpha Reductase Inhibitor among Benign Prostatic Hyperplasia Patients, A Nationally Representative Cohort of Korean Men. Journal of Clinical Medicine. 2019; 8(5):733.
https://doi.org/10.3390/jcm8050733
Chicago/Turabian Style
Chang, Jooyoung, Seulggie Choi, Kyuwoong Kim, and Sang Min Park.
2019. "Cardiovascular Safety and Possible Benefit of a 5-Alpha Reductase Inhibitor among Benign Prostatic Hyperplasia Patients, A Nationally Representative Cohort of Korean Men" Journal of Clinical Medicine 8, no. 5: 733.
https://doi.org/10.3390/jcm8050733
APA Style
Chang, J., Choi, S., Kim, K., & Park, S. M.
(2019). Cardiovascular Safety and Possible Benefit of a 5-Alpha Reductase Inhibitor among Benign Prostatic Hyperplasia Patients, A Nationally Representative Cohort of Korean Men. Journal of Clinical Medicine, 8(5), 733.
https://doi.org/10.3390/jcm8050733